Qiming Venture Partners
Venture capitalActively deployingShanghai · Seed–Growth · 11 people tracked
Also known as QIMING CAYMAN, LTD · QIMING GLOBAL MANAGEMENT, LLC
Investment thesis
Qiming Venture Partners invests in and supports Chinese entrepreneurs across technology and healthcare, backing companies from early stages through IPO. The firm emphasizes long-term partnership, providing not only capital but also strategic guidance, industry resources, talent recruitment support, and a global perspective. Its portfolio spans consumer internet, artificial intelligence, autonomous driving, robotics, innovative pharmaceuticals, in-vitro diagnostics, and biotech, reflecting a dual focus on frontier technology and life sciences within the Chinese innovation ecosystem.
Source: firm website, verified Aug 3, 2026.
Team · 11 people
from the firm's website & curated & public directories
What they invest in
from 19 of 424 portfolio companiesBiotech ×8Healthtech ×7Hardware ×4Deep Tech ×3Medical Devices ×3AI & Machine Learning ×2B2B Marketplaces ×2Cleantech ×2
HQs:China×7United States×6Indonesia×1Netherlands×1
Investments · 424 tracked
founders shown can be your intro pathSchrödinger develops computational drug discovery and molecular simulation software for pharmaceutical and biotech companies.
AI & Machine LearningBiotechDeep TechNew York, US
Timothy Wright(Director)Murco Ringnalda(Executive Officer)Ramy Farid(Executive Officer, Director)Charles Ardai(Director)Joshua Distler(Director)Richard Friesner(Director)
WeRide develops autonomous driving technology for vehicles deployed across multiple cities and countries.
AI & Machine LearningMobility & TransportationRobotics
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses at the nasal mucosa to prevent initial infection and transmission.
BiotechHealthtechMedical DevicesLeiden, NL
Koenraad Wiedhaup(Founder and Chief Executive Officer)inRonald Brus(Founder and Chief Growth Officer)inJaap Goudsmit(Founding Scientist and Senior Advisor)in
Shenzhen Micropoint Bio is a life-science company that develops and mass-produces point-of-care diagnostic devices and microfluidic chips, with products covering cardiovascular, inflammation, reproductive, and coagulation testing.
BiotechHealthtechMedical DevicesShenzhen, CN
Austin, US
Brian Magierski(Executive Officer, Director, Promoter)Steve Papermaster(Executive Officer, Director, Promoter)
Board seatGary Rieschel· per SEC Form D
Nuvaira is a privately held medical device company that develops the dNerva Lung Denervation System, a catheter-based technology used in Targeted Lung Denervation to treat overactive airway nerves in patients with obstructive lung diseases such as COPD and asthma.
HealthtechMedical DevicesMinneapolis, US
Geoffrey Duyk(Director)Doug Sisson(Director)Timothy Herbert(Director)Dennis W. Wahr(Executive Officer, Director)Kirk Nielsen(Director)Dave Stassen(Director)
Board seatGary Rieschel· per SEC Form D · $68.2M raise · filed Jan 2022
Browse all 424 investments with full details →
▶224 more tracked companies
JfkbioJhtcmJiayuanJinkongautoJoesfuturefoodJsgaiyaJurenJustmedicalKaiheikejiKaixin001KeChow PharmaKeysinoKingswareKintepKktv5KoalareadingKuwoLagouLanzaTechLeapstackLetel.ComLiangyihuiLiangzizhigeLieshengLih InvestLongbioLongwill.ComLpaminaLtztherapeuticsLuotianyiLupuamcM20GenomicsMafengwoMarvel TechMatrixportMatwingsMech MindMedicaldlMedmotionMedsciMedxtmcMeetfutureMeitu (美图)Meituan DianpingMicrotechmdMitralignMiwuyyMk SemiMOBIKEMogujieMoodytigerMoreticketsMorewisMuchoMuttoincNasn AutoNovamabNovastNovoprotein.ComNurienNurotronNvxcloudsOcegOne ChipOneapmOneaspOpportunistic China Growth StageOricell TherapeuticsOrigenePelliot.ComPetkitPhotoncrystalPicturePluslifePpsPratilipiPrcxiPrimelifescience.ComPrismlabPrmeasureQiangsenmedicalQiming USQingflowQiniuQuickpic.CoRdbioReddoorzReetian.ComRensenergyRiboX TherapeuticsRoborockRoundhealth (圆心科技)RoxmotorRuhnnSanegene BioSanyou MedicalSanyoumedSceneraySchrödingerSequoiadbSgeetSh Eco.ComShanzhenShenogenShenzhou Cell (神州细胞)ShineheShiyunjiShsongliShulanhealthSiereduSingularmedicalSinobiologicalSinocelltechSinomdtSinotauSinovision TechSnssurgical.ComSpeschinaStepfunStructuretxSuhSunnydentalSunyurSupermagSwapSweetomeSynapsorTT4GameTandemaiTasogareTellgenThoroughTigermedTingsnTisencTokenTongshield (同盾科技)TongzhuogameTpmedicalTransparentics (透景)TranswarpTripod GlpTrytrytwTujia (途家网)TungeeTutorabc.ComUBTECHUbtrobotUnisound (云知声)VanclVeerVenus MedtechVinnoVistelVlightvVongihealthVrmedicalWacaiWanwu PoyuanWebcomicsappWecare BioWeDoctorWeDoctor GroupWifigxWowjoyWoxiaoyaWx VisionproXbonlineXellsmartXiaoe TechXiaohongshu (小红书)XiaomiXiaomishuXiaoniaokuaiyanXiaoyiXiudanXskyXy51YanyinYesmroYlhyoilYoaaYpxfoodYuanbaobaoxianYuanXin Tech (MiaoShou Doctor)Yunjichina.ComYunqiYYGZchb WaterZd MedZeenhealthZegoZgbiotechZhaohu365ZhaosuliaoZhixiaolezinc-fiveZjbangerZuoshouyishengZuzuche云知声京ICP备2023001594号-1再鼎同盾科技圆心科技大众点评小满科技小米小米集团 (1810.HK）微医集团摩拜单车 (Mobike)数坤科技文远知行星环智谱华章 (Zhipu AI)海博思创 (Hyperstrong)涂鸦智能 (Tuya Smart)知乎神州细胞美图艾博生物透景途家网
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Qiming Venture Partners invest at?
- Qiming Venture Partners invests at the Seed, Series A, Series B, Growth stages.
- What is Qiming Venture Partners's typical check size?
- Qiming Venture Partners typically writes checks of $5M – $134M.
- What sectors does Qiming Venture Partners focus on?
- Qiming Venture Partners focuses on AI & Machine Learning, Biotech, Consumer, Digital Health, Enterprise Software, Healthtech, Medical Devices, Mobility & Transportation, Robotics, Sector Agnostic.
- Where is Qiming Venture Partners located?
- Qiming Venture Partners is headquartered in Shanghai, CN.
- Does Qiming Venture Partners lead rounds?
- Qiming Venture Partners typically participates in rounds rather than leading them.
Media · Podcasts & interviews
featuring the teamWelcome Gary Rieschel, Founding Managing Partner of Qiming Venture Partners, as the new Chair of Asia Society Northern California Advisory Board. “Gary... | By Asia Society Northern California
Gary Rieschel · facebook.com
Gary Rieschel of Qiming Venture Partners on Big Sky Virtual Town Hall | Gary Rieschel is the Founding Managing Partner of Qiming Venture Partners. EBS spoke with Rieschel about the economic impacts created by the pandemic,... | By Explore Big Sky
Gary Rieschel · facebook.com
Co-investors · 19
Source Code Capital is a Chinese venture capital firm whose team comes from investment management, product/technology, consulting, and media backgrounds.
INCE Capital is a global venture capital firm that invests in early to expansion-stage companies innovating in AI, technology, consumer, and biotech.
5Y Capital positions itself as entrepreneurs who happen to run a venture firm, focusing on finding founders with "crazy" visions that contradict market consensus when others dismiss them as unrealistic. The firm has built a track record of early bets on Chinese tech leaders like Kuaishou, Xiaomi, and SenseTime, while deliberately expanding into new domains like AI infrastructure and biotech despite having no prior experience in those sectors.
Vivo Capital is a global healthcare-focused investment firm operating a multi-strategy platform spanning venture capital, private equity, and public equity. It aims to expand healthcare access and drive innovation through its 'Ecosystem Strategy.'
Granite Asia is a multi-asset investment platform based in Asia that partners with founders to build industry-leading companies, investing across private equity, private credit, and public markets.
Shunwei Capital is a venture capital firm focused on backing founders in high-tech industries, aiming to help entrepreneurs build world-leading enterprises with capital and operational experience.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
Polaris Partners is a venture capital firm that partners with biotech and healthcare entrepreneurs to build transformational companies.
Prosperity7 Ventures is the diversified growth fund of Aramco Ventures, investing globally in next-generation technologies and business models across a wide range of industries.
Illumina Ventures is a venture investor focused on genomics and precision health, aiming to advance innovation and impact in human health.
Notable Capital is an early-stage venture firm that partners closely with founders, providing hands-on operational support through a platform team of experienced operators across hiring, sales, leadership development, storytelling, and engineering.
Dragonfly is a crypto-focused investment fund that backs researchers and builders working to advance the crypto ecosystem.
▶7 more co-investors
RA CapitalAsset Management VenturesDigitalis VenturesAlpha JWC VenturesMPM BioImpactLightspeed China PartnersRTW Investments L.P.
Firms observed investing alongside Qiming Venture Partners, from public investor directories. Shared companies are the overlap with Qiming Venture Partners's recorded portfolio.
Similar investors
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
SBI Investment Korea is a Korean asset management firm within the SBI Group that operates venture capital and private equity funds, positioning itself as a 'New Industry Creator'.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
A globally recognized venture capital firm designed to provide access to highly competitive venture deals to individual investors, consistently recognized for top-decile DPI performance and as one of the most active US venture firms.
Atinum Investment is a South Korean venture capital firm that invests in promising domestic and international startups, guided by a philosophy focused on the intrinsic value of businesses.